- Home
- HRMY vs INSW Comparison
HRMY vs INSW Comparison
Compare HRMY & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- INSW
- Stock Information
- Founded
- HRMY 2017
- INSW 1999
- Country
- HRMY United States
- INSW United States
- Employees
- HRMY N/A
- INSW N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- INSW Semiconductors
- Sector
- HRMY Health Care
- INSW Technology
- Exchange
- HRMY Nasdaq
- INSW Nasdaq
- Market Cap
- HRMY 1.8B
- INSW 1.8B
- IPO Year
- HRMY 2020
- INSW N/A
- Fundamental
- Price
- HRMY $34.94
- INSW $43.28
- Analyst Decision
- HRMY Strong Buy
- INSW Buy
- Analyst Count
- HRMY 9
- INSW 2
- Target Price
- HRMY $55.33
- INSW $52.00
- AVG Volume (30 Days)
- HRMY 627.0K
- INSW 535.9K
- Earning Date
- HRMY 08-05-2025
- INSW 08-06-2025
- Dividend Yield
- HRMY N/A
- INSW 9.24%
- EPS Growth
- HRMY 58.41
- INSW N/A
- EPS
- HRMY 3.10
- INSW 6.47
- Revenue
- HRMY $772,527,000.00
- INSW $860,606,000.00
- Revenue This Year
- HRMY $20.45
- INSW N/A
- Revenue Next Year
- HRMY $17.32
- INSW $1.88
- P/E Ratio
- HRMY $11.29
- INSW $6.69
- Revenue Growth
- HRMY 17.74
- INSW N/A
- 52 Week Low
- HRMY $26.47
- INSW $27.20
- 52 Week High
- HRMY $41.61
- INSW $54.84
- Technical
- Relative Strength Index (RSI)
- HRMY 50.27
- INSW 66.62
- Support Level
- HRMY $34.09
- INSW $39.06
- Resistance Level
- HRMY $36.09
- INSW $42.08
- Average True Range (ATR)
- HRMY 1.42
- INSW 1.12
- MACD
- HRMY -0.19
- INSW 0.23
- Stochastic Oscillator
- HRMY 46.42
- INSW 96.38
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.